UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial

Annals of the rheumatic diseases, 2018-01, Vol.77 (1), p.21-29

2018

Volltextzugriff (PDF)

Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study

Annals of the rheumatic diseases, 2007-07, Vol.66 (7), p.893-899

2007

Volltextzugriff (PDF)

A multicenter, randomized, open study to evaluate the impact of an electronic data capture system on the care of patients with rheumatoid arthritis

Current medical research and opinion, 2007-08, Vol.23 (8), p.1967-1979

2007

Volltextzugriff (PDF)

Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells

Cancer research (Chicago, Ill.), 2006-02, Vol.66 (3), p.1630-1639

2006

Volltextzugriff (PDF)

Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?

Antimicrobial Agents and Chemotherapy, 2014-01, Vol.58 (1), p.309-316

2014

Volltextzugriff (PDF)

Predicting radiation pneumonitis in locally advanced stage II–III non-small cell lung cancer using machine learning

Radiotherapy and oncology, 2019-04, Vol.133, p.106-112

2019

Volltextzugriff (PDF)

The Effects of the Novel, Reversible Epidermal Growth Factor Receptor/ErbB-2 Tyrosine Kinase Inhibitor, GW2016, on the Growth of Human Normal and Tumor-derived Cell Lines in Vitro and in Vivo

Molecular cancer therapeutics, 2001-12, Vol.1 (2), p.85-94

2001

Volltextzugriff (PDF)

The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: Potential therapy for cancer

Cancer research (Chicago, Ill.), 2001-10, Vol.61 (19), p.7196-7203

2001

Volltextzugriff (PDF)

Burnout in Pediatric Residents: Comparing Brief Screening Questions to the Maslach Burnout Inventory

Academic pediatrics, 2019-04, Vol.19 (3), p.251-255

2019

Volltextzugriff (PDF)

Structure-activity studies with high-affinity inhibitors of pyroglutamyl-peptidase II

Biochemical journal, 2005-07, Vol.389 (Pt 2), p.569-576

2005

Volltextzugriff (PDF)

Discovery and Biological Evaluation of Potent Dual ErbB-2/EGFR Tyrosine Kinase Inhibitors: 6-Thiazolylquinazolines

Bioorganic & medicinal chemistry letters, 2003-02, Vol.13 (4), p.637-640

2003

Volltextzugriff (PDF)

Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers

Oncogene, 1996-01, Vol.12 (1), p.169-176

1996

Volltextzugriff (PDF)

115 POSTER Enhanced growth inhibition of HER-2/neu overexpressing tumor cells by combining HER-2/neu specific polyclonal antibodies and other HER-2/neu targeting treatments

European journal of cancer supplements, 2006-11, Vol.4 (12), p.38-38

2006

Volltextzugriff (PDF)

Thermal ionization energy of lithium and lithium-oxygen complexes in single-crystal silicon

The Journal of physics and chemistry of solids, 1969-01, Vol.30 (8), p.2037-2043

1969

Volltextzugriff (PDF)

1 – 15 von 15

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(15)
Mit Volltextzugriff
(13)

Publikationsform

Artikel
(15)

Sprache

Englisch
(15)

Erscheinungsjahr

n.n

Thema

Science & Technology
(13)
Life Sciences & Biomedicine
(12)
Humans
(11)
Female
(10)
Male
(6)
Animals
(5)
Biological And Medical Sciences
(5)
Medical Sciences
(5)
Oncology
(5)
Pharmacology. Drug Treatments
(5)
Enzyme Inhibitors - Pharmacology
(4)
Mice
(4)
Quinazolines - Pharmacology
(4)
Receptor, Erbb-2 - Antagonists & Inhibitors
(4)
Antineoplastic Agents
(3)
Antineoplastic Agents - Pharmacology
(3)
Mice, Scid
(3)
Middle Aged
(3)
Rheumatoid Arthritis
(3)
Structure-Activity Relationship
(3)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial

Open-label, pilot protocol of patients with rheumatoid arthritis who switch to infliximab after an incomplete response to etanercept: the opposite study

A multicenter, randomized, open study to evaluate the impact of an electronic data capture system on the care of patients with rheumatoid arthritis

Activity of the dual kinase inhibitor lapatinib (GW572016) against HER-2-overexpressing and trastuzumab-treated breast cancer cells

Are Vancomycin Trough Concentrations Adequate for Optimal Dosing?

Predicting radiation pneumonitis in locally advanced stage II–III non-small cell lung cancer using machine learning

The Effects of the Novel, Reversible Epidermal Growth Factor Receptor/ErbB-2 Tyrosine Kinase Inhibitor, GW2016, on the Growth of Human Normal and Tumor-derived Cell Lines in Vitro and in Vivo

The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: Potential therapy for cancer

Burnout in Pediatric Residents: Comparing Brief Screening Questions to the Maslach Burnout Inventory

Structure-activity studies with high-affinity inhibitors of pyroglutamyl-peptidase II

Discovery and Biological Evaluation of Potent Dual ErbB-2/EGFR Tyrosine Kinase Inhibitors: 6-Thiazolylquinazolines

Expanded GGGGCC hexanucleotide repeat in non-coding region of C9ORF72 causes chromosome 9p-linked frontotemporal dementia and amyotrophic lateral sclerosis

Overexpression of the Ras-related TC21/R-Ras2 protein may contribute to the development of human breast cancers

115 POSTER Enhanced growth inhibition of HER-2/neu overexpressing tumor cells by combining HER-2/neu specific polyclonal antibodies and other HER-2/neu targeting treatments

Thermal ionization energy of lithium and lithium-oxygen complexes in single-crystal silicon

Suchergebnisse filtern